Omega Healthcare Investors, Inc.
NYSE:OHIREIT - Healthcare Facilities
-$0.86 today
- Market cap
- $14.33B
- Beta
- 0.58
- P/E (TTM)
- 21.0
- EPS (TTM)
- $2.13
- Dividend yield
- 6.00%
Volume 1.84M
Average 2.27M
OHI Depreciation & Amortization
Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.
Omega Healthcare Investors, Inc.NYSE: OHI
Depreciation & Amortization · Q2 FY2026 · quarter ended Jun 2026
Depreciation & amortization grows, but more slowly than its trailing trend
Q2 FY2026 depreciation & amortization of $81.84M rose 1.7% year over year, behind the +4.6% change in trailing-twelve-month depreciation & amortization. Sequentially, it fell 2.7% from the prior quarter. Over 3 fiscal years it compounded at -0.7% a year.
Context
- Depreciation & amortization amounted to 27.1% of revenue in FY2025, down 1.8 pp from a year earlier.
- Depreciation & amortization increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from +1.7% toward the trailing-twelve-month pace of +4.6%.
Sources:Income StatementText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the income statement
- Latest · FY2025
- 325.25M USD
- Year-over-year change
- +6.8%
- 4-year CAGR
- -1.2%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 325.25M | +6.8% |
| FY2024 | 2024-12-31 | 304.65M | -4.7% |
| FY2023 | 2023-12-31 | 319.68M | -3.8% |
| FY2022 | 2022-12-31 | 332.41M | -2.8% |
| FY2021 | 2021-12-31 | 342.01M | — |
Depreciation & Amortization vs competitors
How OHI compares with its peers on the latest reported figures
- OHI's LTM Jun 2026 depreciation & amortization of $330.85M is the 4th highest of the 11 companies compared; the peer median is $280.38M.
- Its year-over-year change of +4.6% is the 8th highest of 10, against a peer median of +25.8%.
- Depreciation & amortization amounts to 25.6% of revenue for OHI, versus a peer median of 22.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $2.68B | +33.1% | +17.0% | 19.6% | |
| LTM Jun 2026 | $1.47B | +23.5% | +8.2% | 22.8% | |
| LTM Sep 2026 | $1.1B | +2.4% | +12.9% | 48.9% | |
| LTM Jun 2026 | $330.85M | +4.6% | -0.7% | 25.6% | |
| LTM Sep 2026 | $312.23M | +43.2% | +3.9% | 11.7% | |
MPTMedical Properties Trust, Inc. | LTM Jun 2026 | $281.95M | -26.8% | -7.6% | 27.7% |
| FY2025 | $278.81M | — | — | 36.2% | |
| LTM Jun 2026 | $209.43M | +21.7% | -0.1% | 24.4% | |
| LTM Sep 2026 | $120.29M | +58.9% | +22.7% | 19.5% | |
| LTM Sep 2026 | $98.11M | +25.8% | +5.8% | 21.5% | |
| LTM Sep 2026 | $49.15M | +36.1% | +0.3% | 12.5% | |
| Peer median (excluding OHI) | $280.38M | +25.8% | +5.8% | 22.1% | |
Competitors are the stored peer set for OHI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.06B | 878.24M | 949.74M | 1.05B | 1.2B |
| Cost of Revenue | 12.26M | 15.5M | 15.03M | 14.56M | 664.93M |
| Gross Profit | 1.05B | 862.74M | 934.72M | 1.04B | 533.17M |
| Gross Margin | 98.8% | 98.2% | 98.4% | 98.6% | 44.5% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 64.63M | 69.4M | 81.5M | 88M | 0 |
| Operating Expenses | 484.38M | 470.47M | 445.74M | 377.17M | (216.27M) |
| Depreciation & Amortization | 342.01M | 332.41M | 319.68M | 304.65M | 325.25M |
| EBITDA | 992.7M | 1B | 810.84M | 947.11M | 1.17B |
| EBITDA Margin | 93.4% | 114.1% | 85.4% | 90.1% | 97.7% |
| Operating Income | 566.17M | 392.28M | 488.97M | 659.66M | 749.44M |
| Operating Margin | 53.3% | 44.7% | 51.5% | 62.7% | 62.6% |
| Interest Income | 0 | 0 | 0 | 0 | 175.11M |
| Interest Expense | 234.6M | 233.24M | 235.53M | 221.72M | 220.54M |
| Other Income / Expenses | (134.03M) | 51.13M | (233.92M) | (231M) | (125.23M) |
| Income Before Tax | 432.14M | 443.4M | 255.05M | 428.66M | 624.22M |
| Pre-Tax Margin | 40.7% | 50.5% | 26.9% | 40.8% | 52.1% |
| Income Tax Expense | 3.84M | 4.56M | 6.26M | 10.86M | 14.75M |
| Net Income | 416.74M | 426.93M | 242.18M | 406.33M | 590.11M |
| Net Margin | 39.2% | 48.6% | 25.5% | 38.6% | 49.3% |
| EPS (Basic) | 1.76 | 1.81 | 1.01 | 1.57 | 2.02 |
| EPS (Diluted) | 1.75 | 1.80 | 1.00 | 1.55 | 1.94 |
| Weighted Avg Shares | 236.93M | 236.26M | 240.49M | 258.12M | 296.1M |
| Weighted Avg Shares (Diluted) | 244.34M | 244.29M | 250.45M | 270.45M | 310.7M |
Omega Healthcare Investors, Inc.
NYSE:OHI
Intrinsic Alpha fair value
Locked
Current Price
$47.09
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.